Dr. Tanja Taivassalo, MD
Claim this profileStudies Duchenne Muscular Dystrophy
1 reported clinical trial
2 drugs studied
More about Tanja Taivassalo, MD
Clinical Trial Related5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Tanja Taivassalo, MD has experience with
- In-home Exercise Training
- Prednisone
Breakdown of trials Tanja Taivassalo, MD has run
Duchenne Muscular Dystrophy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tanja Taivassalo, MD specialize in?
Tanja Taivassalo, MD focuses on Duchenne Muscular Dystrophy and other conditions. In particular, much of their work with Duchenne Muscular Dystrophy has involved dystrophin positive patients, or patients who are undergoing treatment.
Is Tanja Taivassalo, MD currently recruiting for clinical trials?
No, Tanja Taivassalo, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Tanja Taivassalo, MD has studied deeply?
Yes, Tanja Taivassalo, MD has studied treatments such as In-home Exercise Training, Prednisone.
What is the best way to schedule an appointment with Tanja Taivassalo, MD?
Apply for one of the trials that Tanja Taivassalo, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.